Andrew Kayser1. 1. Department of Neurology, Weill Institute for Neurosciences, University of California at San Francisco.
Abstract
PURPOSE OF REVIEW: To address variation in the severity of gambling disorder, this review evaluates the contribution of mesocorticolimbic dopamine neurons to potential behavioral endophenotypes, the influence of individual differences in the dopamine system on gambling and related behaviors, and the possible role for dopaminergic medications in the treatment of gambling disorder. RECENT FINDINGS: Newer work has suggested that dopaminergic dysfunction can lead to increased reward anticipation and a greater sensitivity to uncertainty, which in turn may drive addictive gambling behaviors. In addition, increased impulsivity, a well-recognized risk factor for gambling disorder, has been linked to dopaminergic dysfunction. More recently, emerging evidence has suggested that dopaminergic medications can influence the discounting of delayed rewards. SUMMARY: Dopaminergic drugs that increase the salience of long-term over short-term goals may ameliorate symptoms of impulsive individuals with gambling disorder. More broadly, improved understanding of intermediate behavioral and other phenotypes with a defined neurobiological substrate may allow for personalized treatment of gambling disorder and other psychiatric conditions.
PURPOSE OF REVIEW: To address variation in the severity of gambling disorder, this review evaluates the contribution of mesocorticolimbic dopamine neurons to potential behavioral endophenotypes, the influence of individual differences in the dopamine system on gambling and related behaviors, and the possible role for dopaminergic medications in the treatment of gambling disorder. RECENT FINDINGS: Newer work has suggested that dopaminergic dysfunction can lead to increased reward anticipation and a greater sensitivity to uncertainty, which in turn may drive addictive gambling behaviors. In addition, increased impulsivity, a well-recognized risk factor for gambling disorder, has been linked to dopaminergic dysfunction. More recently, emerging evidence has suggested that dopaminergic medications can influence the discounting of delayed rewards. SUMMARY: Dopaminergic drugs that increase the salience of long-term over short-term goals may ameliorate symptoms of impulsive individuals with gambling disorder. More broadly, improved understanding of intermediate behavioral and other phenotypes with a defined neurobiological substrate may allow for personalized treatment of gambling disorder and other psychiatric conditions.
Authors: D S S Lobo; L Aleksandrova; J Knight; D M Casey; N el-Guebaly; J N Nobrega; J L Kennedy Journal: Mol Psychiatry Date: 2014-09-30 Impact factor: 15.992
Authors: Joshua W Buckholtz; Michael T Treadway; Ronald L Cowan; Neil D Woodward; Rui Li; M Sib Ansari; Ronald M Baldwin; Ashley N Schwartzman; Evan S Shelby; Clarence E Smith; Robert M Kessler; David H Zald Journal: Science Date: 2010-07-30 Impact factor: 47.728
Authors: Ana B Fagundo; Fernando Fernández-Aranda; Rafael de la Torre; Antonio Verdejo-García; Roser Granero; Eva Penelo; Manel Gené; Carme Barrot; Cristina Sánchez; Eva Alvarez-Moya; Cristian Ochoa; Maria Neus Aymamí; Mónica Gómez-Peña; Jose M Menchón; Susana Jiménez-Murcia Journal: J Psychopharmacol Date: 2014-09-18 Impact factor: 4.153